4
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Septic shock

When patients fail to respond to conventional therapy

Pages 205-212 | Published online: 17 May 2016

References

  • Desjars P, Pinaud M, Potel G, et al. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987: 15(2): 134–7
  • Parker MM, Parrillo J. Septic shock and other forms of distributive shock. In: Parrillo J, ed. Current therapy in critical care medicine. St Louis: Mosby-Year Book, 1987: 44–55
  • Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989: 17(5): 426–9
  • Meadows D, Edwards JD, Wilkins RG, et al. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988: 16(7): 663–6
  • Parrillo J. Norepinephrine therapy of human septic shock: a reappraisal. Update Crit Care Med 1987: 2(11): 1–5
  • Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989: 17(2): 179–80
  • Schaer GL, Fink MP, Parrillo JE. Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985: 13(6): 492–6
  • Martin C, Saux P, Albanese J, et al. A new look at norepinephrine to treat human hyperdynamic septic shock. (Abstr) Anesthesiology 1987: 67(Suppl 3A): A648
  • Melchior JC, Pinaud M, Blanloeil Y, et al. Hemodynamic effects of continuous norepinephrine infusion in dogs with and without hyperkinetic endotoxic shock. Crit Care Med 1987: 15(7): 687–91
  • Breslow MJ, Miller CF, Parker SD, et al. Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 1987: 252(2 Pt 2): H291–300
  • Hanson GC. Shock and infection. In: Hanson GC, Wright PL, eds. The medical management of the critically ill. New York: Grune & Stratton, 1978: 371–3
  • Bourdarias JP, Dubourg O, Gueret P, et al. Inotropic agents in the treatment of cardiogenic shock. Pharmacol Ther 1983: 22(1): 53–79

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.